INFLUENCE OF A NEW CLASS OF GSK-3(3 INHIBITORS ON HUMAN ADENOCARCINOMA CELLS
- Authors: Lysenko A.S1, Seliverstov E.S1, Zubareva E.V1
-
Affiliations:
- Belgorod State National Research University
- Issue: Vol 15, No 3S (2020)
- Pages: 99-99
- Section: Articles
- URL: https://genescells.ru/2313-1829/article/view/122852
- DOI: https://doi.org/10.23868/gc122852
- ID: 122852
Cite item
Open Access
Access granted
Abstract
Full Text
About the authors
A. S Lysenko
Belgorod State National Research University
Email: anngeneva@yandex.ru
Belgorod, Russia
E. S Seliverstov
Belgorod State National Research UniversityBelgorod, Russia
E. V Zubareva
Belgorod State National Research UniversityBelgorod, Russia
References
- McCubrey J., Steelman L., Bertrand F. et al. GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget. 2014; 5(10): 2881-911.
- Domoto T., Pyko I., Furuta T. et al. Glycogen synthase kinase-3p is a pivotal mediator of cancer invasion and resistance to therapy. Cancer Sci. 2016; 107(10): 1363-72.
Supplementary files
